Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer

NCT06480864 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Adebrelimab Injection
DRUG: Apatinib Mesylate Tablets
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Etoposide

Sponsor

Yunpeng Liu

Collaborators

[object Object]